MicroStrategy
MSTR
Coinbase
COIN
MARA Holdings
MARA
Meta Platforms
META
NVIDIA
NVDA
US Stock MarketDetailed Quotes
ACHN ACHN
- 0.000
- 0.0000.00%
15min DelayClose Jan 6 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)140.09MShares0.00052wk High0.00P/B0Float Cap0.00052wk Low--Dividend TTM136.70MShs Float0.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
About ACHN Company
Achillion Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on advancing oral small molecule complement system inhibitors into late-stage development and commercialization.
Company Profile
SymbolACHN
Company NameACHN
CEOJoseph Truitt
MarketPink Market
Employees81
Fiscal Year Ends12-31
Websitehttp://www.achillion.com
Company Executives
- Name
- Position
- Salary
- Aradhana Sarin, M.D.
- Director and President
- --
- Michael Elloian
- Director and Treasurer
- --
- Douglas Barry
- Director and Secretary
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.